The new Horizons Psychedelic Stock Index ETF will add new demand and increased visibility for psychedelic drug stocks.

MIKE TYSON caused a stir after scoffing four grams of magic mushrooms on Logan Paul’s podcast.

Victims of racism should take Ecstasy or magic mushrooms to reduce the trauma of their experience, suggests a new study.

Health Canada issues its first Section 56 Exemption for psilocybin use to an Alberta resident.

Mind Cure’s nootropic products are set to launch across 17 locations within North America starting Feb, 2021.

With clinical trials supporting psychedelics, like psilocybin mushrooms for the treatment of obsessive-compulsive disorder, PTSD, opioid addiction, alcoholism, depression and anxiety, it’s only a matter of time before big pharmaceutical companies begin to invest heavily, and incorporate psychedelics into their own drug pipelines.

VANCOUVER, BC, Dec. 29, 2020 /CNW/ – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA” or the “Company”) is pleased to announce that it has added two additional psychedelic compounds to its drug portfolio.

Mind Cure announces a health-and-wellness supplement to support teen mental health.

Two of the most powerful voices in new media are advocating for the mental health benefits of psychedelics in a big way.

The New Jersey legalization bill has hit a snag as Democratic Gov. Phil Murphy wants changes to a decriminalization bill over a technical issue that shields minors from cannabis-related penalties, according to a Patch report. Murphy, a proponent of the reforms, wants to sign both the decriminalization and legalization bills simultaneously but wants cannabis possession penalties for minors to be like those of alcohol: legal for adults 21-and-older to possess and consume but illegal for those who are underage.